Clinical impact of amyloid PET using 18F-florbetapir in patients with cognitive impairment and suspected Alzheimer’s disease: a multicenter study

被引：0

作者：

Hiroshi Matsuda

Kyoji Okita

Yumiko Motoi

Toshiki Mizuno

Manabu Ikeda

Nobuo Sanjo

Koji Murakami

Taiki Kambe

Toshiki Takayama

Kei Yamada

Takashi Suehiro

Keiko Matsunaga

Takanori Yokota

Ukihide Tateishi

Yoko Shigemoto

Yukio Kimura

Emiko Chiba

Takahiro Kawashima

Yui Tomo

Hisateru Tachimori

Yuichi Kimura

Noriko Sato

机构：

[1] National Center of Neurology and Psychiatry,Department of Radiology

[2] Fukushima Medical University,Department of Biofunctional Imaging

[3] Southern Tohoku Research Institute for Neuroscience,Drug Discovery and Cyclotron Research Center

[4] National Center of Neurology and Psychiatry,Integrative Bain Imaging Center

[5] Juntendo University Graduate School of Medicine,Department of Diagnosis, Prevention, and Treatment of Dementia

[6] Kyoto Prefectural University of Medicine,Department of Neurology

[7] Osaka University Graduate School of Medicine,Department of Psychiatry

[8] Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences,Department of Neurology and Neurological Science

[9] Juntendo University Graduate School of Medicine,Department of Radiology

[10] Juntendo University Graduate School of Medicine,Department of Neurology

[11] Juntendo University Graduate School of Medicine,Department of Psychiatry

[12] Kyoto Prefectural University of Medicine,Department of Radiology

[13] Osaka University Graduate School of Medicine,Department of Molecular Imaging in Medicine

[14] Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences,Department of Diagnostic Radiology

[15] Department of Clinical Data Science,Faculty of Informatics

[16] Clinical Research & Education Promotion Division,undefined

[17] National Center of Neurology and Psychiatry,undefined

[18] Cyber Informatics Research Institute,undefined

来源：

Annals of Nuclear Medicine | 2022年 / 36卷

关键词：

Alzheimer’s disease; Amyloid; PET; F-florbetapir;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1039 / 1049

页数：10

共 174 条

[1]

Wong DF(2010)In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir F 18) J Nucl Med 51 913-920

[2]

Rosenberg PB(2012)Florbetapir F 18 study investigators performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer’s disease and cognitively normal subjects J Nucl Med 53 378-384

[3]

Zhou Y(2017)Clinical use and utility of amyloid imaging J Nucl Med 58 1711-1717

[4]

Kumar A(2015)Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis JAMA 313 1939-1949

[5]

Raymont V(2013)Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline Alzheimer Dis Assoc Disord 27 4-15

[6]

Ravert HT(2014)A consecutive case series experience with [ Mol Neurodegener 9 10-1302

[7]

Joshi AD(2016) F] florbetapir PET imaging in an urban dementia center: impact on quality of life, decision making, and disposition J Alzheimers Dis 54 1297-1262

[8]

Pontecorvo MJ(2017)Diagnosing dementia in the clinical setting: can amyloid PET provide additional value over cerebrospinal fluid? Alzheimers Res Ther 9 2-621

[9]

Clark CM(2016)Diagnostic impact of [ J Alzheimers Dis 52 1251-1424

[10]

Carpenter AP(2012)F]flutemetamol PET in early-onset dementia Dement Geriatr Cogn Dis Extra 2 610-299

← 1 2 3 4 5 6 7 8 9 10 →